PerpEquities

Equity

Novo Nordisk A/S (NVO) perpetual futures

NVO perpetual futures on 15 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade NVOUSDT.

Global pharmaceutical firm researching, developing, manufacturing and selling medicines, plus devices like insulin pens, across several regions.

$38.45-0.2%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · KuCoin (NVO/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

15/15 live markets
Venues
15
Live markets
15/15
24h volume
$3.2MCoverage: 12/15 marketsExchange-reported volume: $6.4M
Open interest
$75.4MCoverage: 10/15 markets
Best liquidity
$832.7K
Bitunix
Tightest spread
+2.6 bps
XT.com
Highest volume
$891K
Binance
Settlement mix
USDT · 14/15
Perp/spot vol.
0.01x
Spot volume $434.8M
OI / float
+0.06%
Float $122B
Spot performance
1D-0.23%
5D-0.49%
1M-15.13%
6M+7.41%
YTD-23.92%
1Y-30.25%

Venue matrix

15 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BinanceTradeNVO/USDTTrading$38.44+24.9% APR
+0.023% every 8h
+5.2 bps$196K$891K$2.8MUSDT-
XT.comTradeNVO/USDTTrading$38.48+11.0% APR
+0.010% every 8h
+2.6 bps$22.4K$837.2K$68.8MUSDT20x
LBankTradeNVO/USDTTrading$38.44+24.9% APR
+0.023% every 8h
+5.2 bps$207.7K$518K-USDT50x
DeepcoinTradeNVO/USDTTrading$38.45-+5.2 bps$117K$438.1K-USDT25x
Gate.ioTradeNVO/USDTTrading$38.470.0% APR
0.000% every 8h
+7.8 bps-$143.7K$1MUSDT20x
MEXCTradeNVO/USDTTrading$38.40+24.7% APR
+0.023% every 8h
+18.2 bps$200.2K$105.6K$1.7MUSDT50x
GRVTTradeNVO/USDTTrading$38.45+53.0% APR
+0.048% every 8h
+10.4 bps$166.4K$104.5K$378.7USDT-
BitunixTradeNVO/USDTTrading$38.45+24.4% APR
+0.022% every 8h
+2.6 bps$832.7K$94.5K-USDT50x
BybitTradeNVO/USDTTrading$38.450.0% APR
0.000% every 8h
+7.8 bps$16.8K$66.2K$900.7KUSDT25x
Helix (Injective)TradeNVO/USDCTrading$38.35+24.1% APR
+0.00275% every 1h
--$14K-USDC12x
HTXTradeNVO/USDTTrading$38.57-+163.3 bps$362.1$2.4K-USDT-
AsterTradeNVOUSDTTrading$38.410.0% APR
0.000% every 8h
+119.6 bps$69.9K$1.2K$1.5KUSDT-
KuCoinTradeNVO/USDTTrading$38.54+3.2% APR
+0.00290% every 8h
+10.4 bps$4.4K$1.3M⚠$116.1KUSDT10x
BingXTradeNVO-USDTTrading$38.45+23.2% APR
+0.021% every 8h
+10.4 bps$240.4K$1.2M⚠$3.8KUSDT-
OurbitTradeNVO/USDTTrading$38.44+24.7% APR
+0.023% every 8h
+7.8 bps$468.9K$649.5K⚠$108.3KUSDT50x

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Broad liquidity · 10 of 15 venues absorb $10k · Typical cost: +13.7 bps – +39.7 bps

Too thin: KuCoin

No fresh book data: Aster, HTX, Gate.io, Helix (Injective)

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

NVO

Tightest spread

NVO

Highest volume

NVO

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 50m ago
Market cap
$171.9B
Updated 50m ago
Revenue
$50.1B
Trailing 12 months
Revenue growth
-2%
Next fiscal year
Profit margin
+35.3%
P/E
9.6
Peer P/E 21.8
Free cash flow
$7.4B
Trailing 12 months
More metrics
Net income
$17.7B
Trailing 12 months
P/S
3.4
Peer P/E
21.8
Similar listed perps
Revenue estimate
$46.1B
Next fiscal year
Earnings
2026-11-04
Revenue est. $11.2B · Updated 50m ago
Dividend
$0.579
2026-08-17

Fundamental detail

Annual + quarterly
Latest revenue$47B
Net margin+33.1%
Free cash flow$4.4B
Net debt$15.9B
2020$19.3B
2021$21.4B
2022$26.9B
2023$35.3B
2024$44.2B
2025$47B
PeriodRevenueGrowthNet incomeFCF
2020$19.3B+4%$6.4B$4.5B
2021$21.4B+11%$7.3B$7.2B
2022$26.9B+26%$8.4B$9.8B
2023$35.3B+31%$12.7B$10.7B
2024$44.2B+25%$15.4B$10.6B
2025$47B+6%$15.6B$4.4B
PeriodGross marginOperating marginNet marginROEROA
2020+83.5%+42.6%+33.2%+404.8%+176.9%
2021+83.2%+41.7%+33.9%+67.5%+24.6%
2022+83.9%+42.3%+31.4%+66.5%+23.0%
2023+84.6%+44.2%+36.0%+78.5%+26.6%
2024+84.7%+44.2%+34.8%+70.4%+21.7%
2025+81.0%+41.3%+33.1%+52.8%+18.9%
PeriodCashDebtNet debtCurrent ratio
2020$319.1M$259M-$60.1M0.94
2021$1.6B$4.1B$2.4B0.86
2022$1.9B$3.9B$2B0.89
2023$2.2B$4.1B$1.9B0.82
2024$2.4B$15.6B$13.3B0.74
2025$4B$19.9B$15.9B0.80
PeriodMarket capEnterprise valueP/SP/E
2020$151.1B$151B7.823.6
2021$255.9B$258.3B11.935.2
2022$324B$326B12.038.3
2023$470.3B$472.2B13.336.9
2024$419.9B$433.2B9.527.3
2025$219B$234.9B4.714.0
Q3 2024$10.9B
Q4 2024$13B
Q1 2025$11.9B
Q2 2025$11.7B
Q3 2025$11.4B
Q4 2025$12B
Q1 2026$14.7B
Q2 2026$11.9B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$10.9B+21%$4.2B$4.8B
Q4 2024$13B+30%$4.3B-$647.8M
Q1 2025$11.9B+19%$4.4B$1.5B
Q2 2025$11.7B+13%$4B$3.7B
Q3 2025$11.4B+5%$3B$4.7B
Q4 2025$12B-8%$4.1B-$5.5B
Q1 2026$14.7B+24%$7.4B$1.8B
Q2 2026$11.9B+2%$3.2B$6.5B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+84.1%+47.4%+38.3%+22.7%+6.9%
Q4 2024+84.8%+42.9%+32.9%+19.7%+6.1%
Q1 2025+83.5%+49.7%+37.2%+21.0%+5.9%
Q2 2025+83.3%+43.5%+34.5%+15.8%+5.5%
Q3 2025+76.1%+31.6%+26.7%+11.8%+3.9%
Q4 2025+80.9%+40.1%+34.0%+13.9%+5.0%
Q1 2026+86.0%+61.6%+50.2%+23.9%+8.7%
Q2 2026+78.2%+34.5%+26.7%+9.5%+3.5%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$8.7B$8.7B-$7M0.94
Q4 2024$2.4B$15.6B$13.3B0.74
Q1 2025$5.9B$18.1B$12.1B0.74
Q2 2025$2.8B$15.1B$12.3B0.78
Q3 2025$4.9B$15.4B$10.5B0.78
Q4 2025$4B$19.9B$15.9B0.80
Q1 2026$3.2B$22.3B$19.1B0.79
Q2 2026$6.8B$21.3B$14.6B0.87
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$540.2B$540.2B49.832.5
Q4 2024$419.9B$433.1B32.224.4
Q1 2025$323.6B$335.7B27.218.3
Q2 2025$295.6B$307.9B25.318.3
Q3 2025$238.8B$249.3B20.919.6
Q4 2025$219B$234.9B18.213.3
Q1 2026$160.6B$179.7B10.95.4
Q2 2026$211.4B$225.9B17.716.5

Refreshed 50m ago

Charts: revenue, profit, cash flow & valuation
Revenue$11.9BQ2 2026
$3.7B$7.4B$11B$14.7BQ3 2023: $8.9BQ4 2023: $10BQ1 2024: $9.9BQ2 2024: $10.4BQ3 2024: $10.9BQ4 2024: $13BQ1 2025: $11.9BQ2 2025: $11.7BQ3 2025: $11.4BQ4 2025: $12BQ1 2026: $14.7BQ2 2026: $11.9BQ3 2023Q2 2026
Net income$3.2BQ2 2026
$1.8B$3.7B$5.5B$7.4BQ3 2023: $3.4BQ4 2023: $3.3BQ1 2024: $3.9BQ2 2024: $3.1BQ3 2024: $4.2BQ4 2024: $4.3BQ1 2025: $4.4BQ2 2025: $4BQ3 2025: $3BQ4 2025: $4.1BQ1 2026: $7.4BQ2 2026: $3.2BQ3 2023Q2 2026
EBITDA$5.9BQ2 2026
$2.6B$5.3B$7.9B$10.5BQ3 2023: $5BQ4 2023: $4.3BQ1 2024: $5.6BQ2 2024: $5.4BQ3 2024: $5.7BQ4 2024: $7BQ1 2025: $7BQ2 2025: $6.6BQ3 2025: $5.1BQ4 2025: $6BQ1 2026: $10.5BQ2 2026: $5.9BQ3 2023Q2 2026
Free cash flow$6.5BQ2 2026
-$2.5B$470.2M$3.5B$6.5BQ3 2023: $4.6BQ4 2023: -$1BQ1 2024: $807.2MQ2 2024: $5.7BQ3 2024: $4.8BQ4 2024: -$647.8MQ1 2025: $1.5BQ2 2025: $3.7BQ3 2025: $4.7BQ4 2025: -$5.5BQ1 2026: $1.8BQ2 2026: $6.5BQ3 2023Q2 2026
EPS$0.72Q2 2026
$0.42$0.83$1.25$1.66Q3 2023: $0.76Q4 2023: $0.75Q1 2024: $0.86Q2 2024: $0.68Q3 2024: $0.93Q4 2024: $0.96Q1 2025: $0.99Q2 2025: $0.91Q3 2025: $0.68Q4 2025: $0.92Q1 2026: $1.66Q2 2026: $0.72Q3 2023Q2 2026
Cash / Debt$6.8BQ2 2026
$5.6B$11.1B$16.7B$22.3BQ3 2023 · Cash: $651.2MQ3 2023 · Debt: $573.3MQ4 2023 · Cash: $2.2BQ4 2023 · Debt: $4.1BQ1 2024 · Cash: $962.3MQ1 2024 · Debt: $4.1BQ2 2024 · Cash: $1.2BQ2 2024 · Debt: $1.2BQ3 2024 · Cash: $8.7BQ3 2024 · Debt: $8.7BQ4 2024 · Cash: $2.4BQ4 2024 · Debt: $15.6BQ1 2025 · Cash: $5.9BQ1 2025 · Debt: $18.1BQ2 2025 · Cash: $2.8BQ2 2025 · Debt: $15.1BQ3 2025 · Cash: $4.9BQ3 2025 · Debt: $15.4BQ4 2025 · Cash: $4BQ4 2025 · Debt: $19.9BQ1 2026 · Cash: $3.2BQ1 2026 · Debt: $22.3BQ2 2026 · Cash: $6.8BQ2 2026 · Debt: $21.3BQ3 2023Q2 2026
CashDebt
Profitability+78.2%Q2 2026
+21.5%+43.0%+64.5%+86.0%Q3 2023 · Gross margin: +83.5%Q4 2023 · Gross margin: +84.8%Q1 2024 · Gross margin: +84.8%Q2 2024 · Gross margin: +84.9%Q3 2024 · Gross margin: +84.1%Q4 2024 · Gross margin: +84.8%Q1 2025 · Gross margin: +83.5%Q2 2025 · Gross margin: +83.3%Q3 2025 · Gross margin: +76.1%Q4 2025 · Gross margin: +80.9%Q1 2026 · Gross margin: +86.0%Q2 2026 · Gross margin: +78.2%Q3 2023 · Operating margin: +45.8%Q4 2023 · Operating margin: +40.6%Q1 2024 · Operating margin: +48.7%Q2 2024 · Operating margin: +38.1%Q3 2024 · Operating margin: +47.4%Q4 2024 · Operating margin: +42.9%Q1 2025 · Operating margin: +49.7%Q2 2025 · Operating margin: +43.5%Q3 2025 · Operating margin: +31.6%Q4 2025 · Operating margin: +40.1%Q1 2026 · Operating margin: +61.6%Q2 2026 · Operating margin: +34.5%Q3 2023 · Net margin: +38.3%Q4 2023 · Net margin: +33.3%Q1 2024 · Net margin: +38.9%Q2 2024 · Net margin: +29.5%Q3 2024 · Net margin: +38.3%Q4 2024 · Net margin: +32.9%Q1 2025 · Net margin: +37.2%Q2 2025 · Net margin: +34.5%Q3 2025 · Net margin: +26.7%Q4 2025 · Net margin: +34.0%Q1 2026 · Net margin: +50.2%Q2 2026 · Net margin: +26.7%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+2.1%Q2 2026
+1.8%+11.2%+20.7%+30.1%Q2 2024: +23.2%Q3 2024: +21.4%Q4 2024: +30.1%Q1 2025: +19.5%Q2 2025: +12.9%Q3 2025: +5.1%Q4 2025: -7.6%Q1 2026: +24.0%Q2 2026: +2.1%Q3 2023Q2 2026
Shares outstanding4.4BQ2 2026
1.1B2.2B3.4B4.5BQ3 2023: 4.5BQ4 2023: 4.5BQ1 2024: 4.5BQ2 2024: 4.5BQ3 2024: 4.5BQ4 2024: 4.5BQ1 2025: 4.4BQ2 2025: 4.4BQ3 2025: 4.4BQ4 2025: 4.4BQ1 2026: 4.4BQ2 2026: 4.4BQ3 2023Q2 2026
Valuation16.5Q2 2026
16.533.049.566.1Q3 2023 · P/E: 31.9Q4 2023 · P/E: 35.0Q1 2024 · P/E: 38.8Q2 2024 · P/E: 56.0Q3 2024 · P/E: 32.5Q4 2024 · P/E: 24.4Q1 2025 · P/E: 18.3Q2 2025 · P/E: 18.3Q3 2025 · P/E: 19.6Q4 2025 · P/E: 13.3Q1 2026 · P/E: 5.4Q2 2026 · P/E: 16.5Q3 2023 · P/S: 48.9Q4 2023 · P/S: 46.7Q1 2024 · P/S: 60.4Q2 2024 · P/S: 66.1Q3 2024 · P/S: 49.8Q4 2024 · P/S: 32.2Q1 2025 · P/S: 27.2Q2 2025 · P/S: 25.3Q3 2025 · P/S: 20.9Q4 2025 · P/S: 18.2Q1 2026 · P/S: 10.9Q2 2026 · P/S: 17.7Q3 2023Q2 2026
P/EP/S
Revenue$47B2025
$11.8B$23.5B$35.3B$47B2018: $17B2019: $18.6B2020: $19.3B2021: $21.4B2022: $26.9B2023: $35.3B2024: $44.2B2025: $47B20182025
Net income$15.6B2025
$3.9B$7.8B$11.7B$15.6B2018: $5.9B2019: $5.9B2020: $6.4B2021: $7.3B2022: $8.4B2023: $12.7B2024: $15.4B2025: $15.6B20182025
EBITDA$23.8B2025
$6B$11.9B$17.9B$23.8B2018: $7.9B2019: $8.3B2020: $9B2021: $10B2022: $11.7B2023: $17.4B2024: $22.5B2025: $23.8B20182025
Free cash flow$4.4B2025
$2.7B$5.3B$8B$10.7B2018: $4.9B2019: $5.4B2020: $4.5B2021: $7.2B2022: $9.8B2023: $10.7B2024: $10.6B2025: $4.4B20182025
EPS$3.52025
$0.88$1.75$2.63$3.52018: $1.212019: $1.252020: $1.372021: $1.582022: $1.862023: $2.832024: $3.442025: $3.520182025
Cash / Debt$4B2025
$5B$10B$14.9B$19.9B2018 · Cash: $2.4B2018 · Debt: $78.4M2019 · Cash: $353.7M2019 · Debt: $102.5M2020 · Cash: $319.1M2020 · Debt: $259M2021 · Cash: $1.6B2021 · Debt: $4.1B2022 · Cash: $1.9B2022 · Debt: $3.9B2023 · Cash: $2.2B2023 · Debt: $4.1B2024 · Cash: $2.4B2024 · Debt: $15.6B2025 · Cash: $4B2025 · Debt: $19.9B20182025
CashDebt
Profitability+81.0%2025
+21.2%+42.3%+63.5%+84.7%2018 · Gross margin: +84.2%2019 · Gross margin: +83.5%2020 · Gross margin: +83.5%2021 · Gross margin: +83.2%2022 · Gross margin: +83.9%2023 · Gross margin: +84.6%2024 · Gross margin: +84.7%2025 · Gross margin: +81.0%2018 · Operating margin: +42.2%2019 · Operating margin: +43.0%2020 · Operating margin: +42.6%2021 · Operating margin: +41.7%2022 · Operating margin: +42.3%2023 · Operating margin: +44.2%2024 · Operating margin: +44.2%2025 · Operating margin: +41.3%2018 · Net margin: +34.5%2019 · Net margin: +31.9%2020 · Net margin: +33.2%2021 · Net margin: +33.9%2022 · Net margin: +31.4%2023 · Net margin: +36.0%2024 · Net margin: +34.8%2025 · Net margin: +33.1%20182025
Gross marginOperating marginNet margin
Revenue growth+6.4%2025
+7.8%+15.6%+23.4%+31.3%2019: +9.1%2020: +4.0%2021: +10.9%2022: +25.7%2023: +31.3%2024: +25.0%2025: +6.4%20182025
Shares outstanding4.4B2025
1.2B2.4B3.6B4.8B2018: 4.8B2019: 4.8B2020: 4.7B2021: 4.6B2022: 4.5B2023: 4.5B2024: 4.5B2025: 4.4B20182025
Valuation14.02025
9.619.228.838.32018 · P/E: 18.82019 · P/E: 23.52020 · P/E: 23.62021 · P/E: 35.22022 · P/E: 38.32023 · P/E: 36.92024 · P/E: 27.32025 · P/E: 14.02018 · P/S: 6.52019 · P/S: 7.52020 · P/S: 7.82021 · P/S: 11.92022 · P/S: 12.02023 · P/S: 13.32024 · P/S: 9.52025 · P/S: 4.720182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-04
Revenue est. $11.2B · Updated 50m ago
Dividend
$0.579
2026-08-17

No unusual perp activity right now.

FMP reference data

Market context

Reference market

Closed
New York Stock Exchange
Regular hours
09:30 AM – 04:00 PM
Next holiday
Nov 26, 2026 · Thanksgiving Day

After-hours reference

Bid38.37
Ask38.4
Volume222,598

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202622.38$46.1B-2%7
FY 202722.05$46.8B-1%7
FY 202823.99$49.6B+5%4
FY 202927.47$53.5B+14%2
FY 203028.43$55.5B+18%4
Q3 20265.01$11.2B-2%4

Company events

6
2026-11-04EarningsActual - / Estimate 0.76-
2026-08-17Dividend$0.579-
2026-08-05EarningsActual 0.96 / Estimate 0.82Beat
2026-05-06EarningsActual 1.04 / Estimate 0.87Beat
2026-03-30Dividend$1.217-
2026-02-03EarningsActual 1 / Estimate 0.9Beat

Peer comparison

Similar listed perps

FMP company data

Company intelligence

Updated: Sep 29, 2026, 12:18 PM UTC

Company profile

Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Maziar Mike Doustdar
Employees
68,794
IPO date
Apr 30, 1981
Country
DK
Exchange
New York Stock Exchange
Website
Altman Z-scorei3.69
Piotroski scorei6/9
FMP ratingiA-
Owner earningsiDKK 43.10BDKK 9.72 per share
ESG risk ratingiB-Industry rank: 28 out of 28

Rating factors

Return on equityi
5
Return on assetsi
5
Debt to equityi
2
Price to earningsi
2
Price to booki
1
Market cap history
$170.39B-20.7%Jun 26 – Sep 26
$170.39B$195.53B$220.66BHigh: $220.66B · 2026-07-27Latest: $170.39B · 2026-09-28Jun 26Jul 26Aug 26Sep 26
Latest: $170.39B · 2026-09-28High: $220.66B · 2026-07-27Low: $170.39B · 2026-09-28
Largest fund holders
FundWeightShares held
PPH5.62%1.5M
AVDE0.27%1.3M
WCMI1.49%804.2K
PID2.02%444.9K
RODM0.69%291.1K
AVIV0.54%290.4K
LIFE.TO3.85%245.2K
APIE0.68%203.2K
OZEM11.23%168.7K
AQEC0.6%93.7K
NVOH95.4%89.5K
AVDEX0.35%81K

Analyst track record

How the analysts covering NVO have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings58171
Analysts1224
Buy / hold / sell13 / 42 / 399 / 65 / 7
Upgrades / downgrades / initiations2 / 9 / 06 / 15 / 7
Price targets hit / missed0 / 50 (0%)0 / 139 (0%)
Avg. return after a rating (TipRanks)-21.4%-47.9%
Best / worst call-3.5% / -44.8%-3.5% / -82.0%

After buy calls on this stock: median 21-day move +2.3% vs S&P 500 +0.1% (n = 100)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Sachin JainBank of America Securities36% hit rate on this stock · 11 targets measuredHoldtarget $57.81Oct 9, 2025
  2. Michael NedelcovychTD Cowen13% hit rate on this stock · 15 targets measuredHoldtarget $42.00Sep 22, 2026
  3. Evan SeigermanBMO Capital0% hit rate on this stock · 19 targets measuredHoldtarget $47.00Sep 21, 2026

Latest ratings

DateAnalystCallTarget
Sep 22, 2026Michael NedelcovychTD CowenHoldMaintained$42.00
Sep 22, 2026Michael NedelcovychTD CowenHoldMaintained$42.00
Sep 22, 2026Unknown AnalystJefferiesHoldMaintained$42.20
Sep 21, 2026Evan SeigermanBMO CapitalHoldMaintained$47.00
Sep 22, 2026Unknown AnalystJefferiesHoldMaintained$42.20
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$35.00$40.00$45.00$50.00$55.00$60.00$65.00Oct 25 · Buy 6 · Hold 3 · Sell 1Oct 25Nov 25 · Buy 8 · Hold 3 · Sell 1Dec 25 · Buy 6 · Hold 5 · Sell 1Dec 25Jan 26 · Buy 6 · Hold 5 · Sell 1Feb 26 · Buy 6 · Hold 6 · Sell 1Feb 26Mar 26 · Buy 2 · Hold 9 · Sell 0Apr 26 · Buy 2 · Hold 8 · Sell 0Apr 26May 26 · Buy 1 · Hold 8 · Sell 0Jun 26 · Buy 1 · Hold 7 · Sell 0Jun 26Jul 26 · Buy 1 · Hold 7 · Sell 0Aug 26 · Buy 0 · Hold 5 · Sell 0Aug 26Sep 26 · Buy 0 · Hold 6 · Sell 1Oct 25 · avg. target $63.91Nov 25 · avg. target $61.25Dec 25 · avg. target $55.03Jan 26 · avg. target $56.78Feb 26 · avg. target $56.32Mar 26 · avg. target $46.75Apr 26 · avg. target $44.83May 26 · avg. target $44.83Jun 26 · avg. target $44.20Jul 26 · avg. target $44.20Aug 26 · avg. target $45.00Sep 26 · avg. target $43.70Oct 25 · month-end close $49.46Nov 25 · month-end close $49.35Dec 25 · month-end close $50.88Jan 26 · month-end close $59.43Feb 26 · month-end close $37.45Mar 26 · month-end close $36.75Apr 26 · month-end close $42.22May 26 · month-end close $45.58Jun 26 · month-end close $47.94Jul 26 · month-end close $47.08Aug 26 · month-end close $45.33Sep 26 · month-end close $38.80

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 25, 2026 · 58 ratings

Frequently asked questions

Where can I trade NVO perpetual futures?

Novo Nordisk A/S (NVO) perpetual futures trade on 15 crypto venues, including KuCoin, BingX, Binance. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade NVO around the clock?

Yes. Unlike the underlying stock, NVO perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on NVO perpetuals?

Right now the NVO perp funding rate is +24.1% annualized (venue median), ranging from 0.0% to +53.0% across 15 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the NVO perp price compare to the Novo Nordisk A/S stock?

The venue-median NVO perp mark is $38.5 versus a reference stock price of $38.5, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a NVO perpetual future?

A NVO perpetual is a derivative that tracks the price of Novo Nordisk A/S with no expiry date. It lets you take long or short exposure to Novo Nordisk A/S on crypto venues, around the clock.

What is NVOUSDT perpetual?

NVOUSDT is the symbol most crypto exchanges use for the Novo Nordisk A/S perpetual settled in USDT (Tether). It tracks the NVO share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

NVO perpetuals · perpequities.comNVO perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/nvo-perp"><img src="https://perpequities.com/badge/nvo-perp.svg" width="240" height="64" alt="NVO perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of NVO perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for NVO — one email every Sunday.

Watchlist and alerts

Price and funding alerts for NVO, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X